A PHARMACOLOGICAL REVIEW ON HEAD AND NECK CANCER
- Mahesh Pavan Kontheti,
- Upajna Vamaraju,
- Navya Deepika Burreddy,
- Rushi Naidu Tarra
Abstract
Head and neck cancer are a group of cancers of the mouth, sinuses, nose
or throat, where smoking is considered a major risk factor. Symptoms may
appear in mouth, sinuses, nose or throat and include a sore or lump that
doesn't heal, a persistent sore throat, trouble swallowing and changes
in the voice. Prognosis in this type of cancer generally depends on the
size of tumor, primary site, causative factor, and presence of local or
distant metastases. In general, the prognosis is favourable if diagnosis
is early and treatment is timely and appropriate. Treatment includes
surgery, radiation therapy or chemotherapy. Staging of tumor can be done
using TNM classification and the can be evaluated through RECIST
guidelines. Removing risk factors is very much important in preventing
this type of cancer, and patients should stop the usage of tobacco and
limit alcohol consumption.